SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Thursday reported a loss of $19.7 million in its fourth quarter.
The San Diego-based company said it had a loss of 99 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share.
For the year, the company reported that its loss widened to $83.1 million, or $4.20 per share.
Mirati shares have increased 12 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.30, a fall of 75 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX
Keywords: Mirati, Earnings Report